Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 71

Results For "Covid"

1174 News Found

Study shows Pfizer vaccine moderately effective against Omicron for children 5-15
News | March 12, 2022

Study shows Pfizer vaccine moderately effective against Omicron for children 5-15

The study looked at 1,364 children in Arizona, Florida, Texas, and Utah who submitted weekly nasal swabs and surveys from July 2021 through February 2022, regardless of whether they had symptoms


Moderna begins Phase 2 study of Omicron-specific bivalent booster
Biotech | March 11, 2022

Moderna begins Phase 2 study of Omicron-specific bivalent booster

Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine


Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants
Biotech | March 10, 2022

Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants

Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study


Non-invasive leadless pacemaker implanted in a 60-year-old at Fortis Hospital, Malar
Hospitals | March 10, 2022

Non-invasive leadless pacemaker implanted in a 60-year-old at Fortis Hospital, Malar

The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully


Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards
Clinical Trials | March 10, 2022

Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards

As a part of its CSR initiatives, the ‘Healthcare Heroes of India’ Awards by Metropolis aims to identify and recognize those individuals and institutions in healthcare sector with a strong sense of purpose and commitment towards patient care and who have prioritized it over all other growth parameters


AXA in India boosts telemedicine helpline with free specialist teleconsultation feature
Digitisation | March 10, 2022

AXA in India boosts telemedicine helpline with free specialist teleconsultation feature

SAATH is a ‘One AXA’ public health initiative between AXA France Vie, AXA GO Business Operations, and AXA XL


Alvotech settles with AbbVie to secure US rights to Humira biosimilar
Biotech | March 09, 2022

Alvotech settles with AbbVie to secure US rights to Humira biosimilar

Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023


SII’s Covovax approved for 12-17 years age group
News | March 09, 2022

SII’s Covovax approved for 12-17 years age group

The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021


Organon declares paid time off for all employees on International Women’s Day
News | March 08, 2022

Organon declares paid time off for all employees on International Women’s Day

As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health


Industry upbeat on biopharma sector
News | March 08, 2022

Industry upbeat on biopharma sector

Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector